Oruka Therapeutics Inc
NASDAQ:ORKA

Watchlist Manager
Oruka Therapeutics Inc Logo
Oruka Therapeutics Inc
NASDAQ:ORKA
Watchlist
Price: 30.18 USD -0.1% Market Closed
Market Cap: 1.5B USD

Net Margin
Oruka Therapeutics Inc

0%
Current
0%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-101.6m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Oruka Therapeutics Inc
Glance View

Market Cap
1.5B USD
Industry
Biotechnology

Oruka Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Westminster, Colorado and currently employs 4 full-time employees. The company went IPO on 2000-07-21. Oruka Therapeutics, Inc., formerly ARCA biopharma, Inc., is a biotechnology company. The firm is engaged in developing novel biologics designed for the treatment of chronic skin diseases, including plaque psoriasis. The company is advancing a proprietary portfolio of potential antibodies that target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. The Company’s lead programs include ORKA-001 and ORKA-002, which are designed to block cytokines in the pathogenesis of psoriasis and other inflammatory diseases. ORKA-001 is a potentially monoclonal antibody designed to inhibit IL-23p19 for the treatment of psoriasis. ORKA-001 targets the p19 subunit of interleukin-23 (IL-23p19). ORKA-002 is a potentially monoclonal antibody designed to inhibit IL-17A/F for the treatment of psoriasis, psoriatic arthritis, and other conditions. ORKA-002 targets interleukin-17A and interleukin-17F (IL-17A/F).

ORKA Intrinsic Value
10.35 USD
Overvaluation 66%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-101.6m
/
Revenue
0
What is the Net Margin of Oruka Therapeutics Inc?

Based on Oruka Therapeutics Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top